Downloadable PDFs from the device manufacturer, kept at the same filenames used on the main Urology NSW site, plus a written transcript of the explainer video.
The wider set of practice leaflets is available on the main Urology NSW patient information brochures page.
Full transcript of the introductory video on the home page, for readers who prefer text.
Hi, I'm Raji Kooner. For the last 25 years, I've been providing specialist urology services in Sydney at a variety of hospitals, including St Vincent's Private Hospital, Mater Hospital, and East Sydney Private Hospital.
I'm delighted today to talk about a new, innovative treatment for moderate to severe BPH called the iTind. iTind stands for "temporary implantable device". It utilises the unique properties of nitinol wire, a nickel and titanium shape-memory alloy, making it ideal for use in endoscopic procedures.
This device reshapes the prostate and is typically used for prostates under 60 cc, although it has also been used in glands larger than 80 cc. Notably, the iTind procedure does not cause sexual dysfunction, does not involve permanent implants, and does not require injection into the prostate.
The iTind device is inserted via a cystoscope and anchored just below the bladder neck. It stays in place for 5 to 7 days, expanding gradually to compress the prostate tissue. This compression creates three channels, at the 5, 7, and 12 o'clock positions, improving urine flow.
After 5 to 7 days, the device is removed via a sheath. The removal process is quick and typically done under light sedation in an outpatient setting. The overall procedure is minimally invasive and in Australia is usually performed in a day-surgery unit.
Prior to the procedure, standard assessments such as urine flow testing, ultrasound, urine culture, and flexible cystoscopy are performed. Patients are also reviewed by an anaesthetist, who discusses expectations and plans post-procedure care including pain relief and antispasmodics.
Removal of the device involves gently pulling it out using a snare through a catheter, and it typically reverts to its original shape once removed. The entire experience is designed to be low-impact for the patient while providing meaningful symptom relief.
iTind represents a significant step forward in minimally invasive urological care, and I believe it is an excellent alternative for patients seeking to avoid long-term medication or more invasive surgery.
Thank you for watching.
You can ask for a second opinion on your urinary symptoms, flow studies and treatment options before committing to a plan.